1. Home
  2. EVTV vs CTXR Comparison

EVTV vs CTXR Comparison

Compare EVTV & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$1.72

Market Cap

21.6M

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.85

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTV
CTXR
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
18.9M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
EVTV
CTXR
Price
$1.72
$0.85
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
904.0K
405.2K
Earning Date
04-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
$5,939,008.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
217.58
N/A
52 Week Low
$0.15
$0.63
52 Week High
$5.07
$2.38

Technical Indicators

Market Signals
Indicator
EVTV
CTXR
Relative Strength Index (RSI) 49.68 53.91
Support Level $1.63 $0.66
Resistance Level $2.40 $0.98
Average True Range (ATR) 0.14 0.07
MACD 0.02 0.01
Stochastic Oscillator 45.54 68.21

Price Performance

Historical Comparison
EVTV
CTXR

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: